Melanocortin peptide therapy for the treatment of arthritic pathologies

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 1394-1414

  Getting, S J ^a   Kaneva, M ^a   Bhadresa, Y ^a   Renshaw, D ^a   Leoni, Giovanna ^b   Patel, H B ^b   Kerrigan, M J P ^a   Locke, I C ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anti inflammatory; Chemokine; Cytokine; Gout; Macrophage; Melanocortin; Migration; Neutrophil; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; ALPHA INTERMEDIN; CELECOXIB; CORTICOTROPIN; CORTICOTROPIN[1-39]; CORTICOTROPIN[4-10]; CYTOKINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; ETORICOXIB; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; HYDROCORTISONE; INFLIXIMAB; LUMIRACOXIB; MELANOCORTIN; MELANOCORTIN RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PROOPIOMELANOCORTIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; TRIAMCINOLONE; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CYTOKINE RELEASE; DOWN REGULATION; EXTRAVASATION; GOUT; HUMAN; INFANCY; LEUKOCYTE; LEUKOCYTE MIGRATION; NONHUMAN; OSTEOARTHRITIS; PROTEIN INDUCTION; RECEPTOR BINDING; REPORTER GENE; REVIEW; RHEUMATOID ARTHRITIS; RISK REDUCTION; ANIMAL; DRUG EFFECT; INFLAMMATION; SIGNAL TRANSDUCTION;

ANIMALIA;

ANIMALS; ARTHRITIS; ARTHRITIS, GOUTY; ARTHRITIS, RHEUMATOID; HUMANS; INFLAMMATION; MELANOCORTINS; OSTEOARTHRITIS; RECEPTORS, MELANOCORTIN; SIGNAL TRANSDUCTION;

EID: 77449099049     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.163     Document Type: Review

References (145)

1. Bajekal, M., Osborne, V., Yar, M., and Meltzer, H. (2006) Focus on Health. Office of National Statistics, U.K.
2. March, L.M. and Bachmeier, C.M.J. (1997) Economics of osteoarthritis: a global perspective. Baillieres Clin. Rheumatol. 11, 817-834.
3. Buckwalter, J.A. and Mankin, H.J. (1997) Articular cartilage part II: degeneration and osteoarthrosis, repair, regeneration and transplantation. J. Bone Joint Surg. Am. 79-A, 612-632.
4. Kim, H.A. and Blanco, F.J. (2007) Cell death and apoptosis in osteoarthritic cartilage. Curr. Drug Targets 8, 333-345.
5. Martin, J.A. and Buckwalter, J.A. (2002) Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerentology 3, 257-264.
6. Mobasheri, A. (2002) Role of chondrocyte death and hypocellularity in ageing human articular cartilage and the pathogenesis of osteoarthritis. Med. Hypotheses 58, 193-197.
7. Lee, D.M. and Weinblatt, M.E. (2001) Rheumatoid arthritis. Lancet 358, 903-911.
8. Brennan, F.M. and McInnes, I.B. (2008) Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 118, 3537-3545.
9. van Venrooij, W.J, van Beers, J.J.B.C., and Pruijn, G.J.M. (2008) Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1143, 268-285.
10. Cronstein, B.N. and Terkeltaub, R. (2006) The inflammatory process of gout and its treatment. Arthritis Res. Ther. 8(Suppl. 1), S3.
11. So, A. (2008) Developments in the scientific and clinical understanding of gout. Arthritis Res. Ther. 10, 221-227.
12. Morgan, C., Lunt, M., Brightwell, H., Bradburn, P., Fallow, W., Lay, M., Silman, A., and Bruce, I.N. (2003) Contribution of patient related differences to multidrug resistance in rheumatoid arthritis. Ann. Rheum. Dis. 62(1), 15-19.
13. Midwood, K., Sacre, S., Piccinini, A.M., Inglis, J., Trebaul, A., Chan, E., Drexler, S., Sofat, N., Kashiwagi, M., Orend, G., Brennan, F., and Foxwell, B. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 15(7), 774-780.
14. Nakagawa, S., Arai, Y., Mori, H., Matsushita, Y., Kubo, T., and Nakanishi, T. (2009) Small interfering RNA targeting CD81 ameliorated arthritis in rats. Biochem. Biophys. Res. Commun. 388(3), 467-472.
15. Doblado, M.A. and Moley, K.H. (2009) Facilitative glucose transporter 9 (GLUT9), a unique hexose and urate transporter. Am. J. Physiol. Endocrinol. Metab. 297(4), E831-835.
16. Torres, R., Macdonald, L., Croll, S.D., Reinhardt, J., Dore, A., Stevens, S., Hylton, D.M., Rudge, J.S., Liu-Bryan, R., Terkeltaub, R.A., Yancopoulos, G.D., and Murphy, A.J. (2009) Hyperalgesia, synovitis, and multiple biomarkers of inflammation are suppressed by IL-1 inhibition in a novel animal model of gouty arthritis. Ann. Rheum. Dis. 68(10), 1602-1608.
17. Rudolphi, K., Gerwin, N., Verziji, N., van der Kraan, P., and van den Berg, W. (2003) Praincasan, an inhibitor of interleukin-1 beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteo Cart. 11(10), 738-746.
18. Murase, A., Okumura, T., Sakakibara, A., Tonai-Kachi, H., and Takada, J. (2008) Effect of prostanoid EP4 receptor antagonist CJ-042,794, in rat models of pain and inflammation. Eur. J. Pharmacol. 580(1-2), 116-121.
19. Hench, P.S. and Kendall, E.C. (1949) The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin. Proc. 24(8), 181-197.
20. Hench, P.S., Kendall, E.C., Slocumb, C.H., and Polley, H.F. (1949) Adrenocortical hormone in arthritis: preliminary report. Ann. Rheum. Dis. 8(2), 97-104.
21. Heinig, J.A., Keeley, F.W., Robson, P., Sower, S.A., and Youson, J.H. (1995) The appearance of proopiomelanocortin early in vertebrate evolution: cloning and sequencing of POMC from a Lamprey pituitary cDNA library. Gen. Comp. Endocrinol. 99, 137-144.
22. Lipton, J.M. and Catania, A. (1997) Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol. Today 18, 140-145.
23. Getting, S.J. (2006) Targeting melanocortin receptors for the treatment of disease pathologies. Pharmacol. Ther. 111(1), 1-15.
24. Takahashi, H., Teranishi, Y., Nakanishi, S., and Numa, S. (1981) Isolation and structural organization of the human corticotropin-beta-lipotropin precursor gene. FEBS Lett. 135, 97-102.
25. Uhler, M. and Herbert, E. (1983) Complete amino acid sequence of mouse pro-opiomelanocortin derived from the nucleotide sequence of pro-opiomelanocortin cDNA. J. Biol. Chem. 258, 257-261.
26. Drouin, J. and Goodman, H.M. (1980) Most of the coding region of rat ACTH beta-LPH precursor gene lacks intervening sequences. Nature 288, 610-613.
27. Castro, M.G. and Morrison., E. (1997) Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crit. Rev. Neurobiol. 11(1), 35-57.
28. Benjannet, S., Rondeau, N., Day, R., Chretien, M., and Seidah, N.G. (1991) PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc. Natl. Acad. Sci. U. S. A. 88, 3564-3568.
29. Bloomfield, G.A., Scott, A.P., Lowry, P.J., Gikes, J.J.H., and Rees, L.H. (1974) A reappraisal of human b-MSH. Nature 252, 492-493.
30. Scott, A.P. and Lowry, P.J. (1974) Adrenocorticotropic and melanocyte-stimulating peptides in the human pituitary. Biochem. J. 139, 593-602.
31. Catania, A., Gatti, S., Colombo, G., and Lipton, J.M. (2004) Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56, 1-29.
32. Kelly, J.M., Moir, A.J., Carlson, K., Yang, Y., MacNeil, S., and Haycock, J.W. (2006) Immobilized alpha-melanocyte stimulating hormone 10-13 (GKPV) inhibits tumour necrosis factor alpha stimulated NF-kappaB activity. Peptides 27, 431-437.
33. Manna, S.K. and Aggarwal, B.B. (1998) a-Melanocyte stimulating hormone inhibits the nuclear transcription factor NF-kB activation by various inflammatory agents. J. Immunol. 161, 2873-2880.
34. Wikberg, J.E., Muceniece, R., Mandrika, I., Prusis, P., Lindblom, J., Post, C., and Skottner, A. (2000) New aspects on the melanocortins and their receptors. Pharmacol. Res. 42, 393-420.
35. Chhajlani, V. and Wikberg, J.E.S. (1992) Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309(3), 417-420.
36. Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., and Cone, R.D. (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
37. Bhardwaj, R., Becher, E., Mahnke, K., Hartmeyer, M., Schwarz, T., Scholzen, T., and Luger, T.A. (1997) Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J. Immunol. 158, 3378-3384.
38. Catania, A., Rajora, N., Capsooni, F., Minonzio, F., Star, R.A., and Lipton, J.M. (1996) The neuropeptide a-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17(4), 675-679.
39. Hartmeyer, M., Scholzen, T., Becher, E., Bhardwaj, R.S., Schwarz, T., and Luger, T.A. (1997) Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. J. Immunol. 159, 1930-1937.
40. Hill, R.P., MacNeil, S., and Haycock, J.W. (2006) Melanocyte stimulating hormone peptides inhbit TNF-alpha signaling in human dermal fibroblast cells. Peptides 27, 421-430.
41. Adachi, S., Nakano, T., Vliagoftis, H., and Metcalfe, D.D. (1999) Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. J. Immunol. 163, 3363-3368.
42. Neumann-Andersen, G., Nagaeva, O., Mandrika, I., Petrovska, R., Muceniece, R., Mincheva-Nilsson, L., and Wikberg, J.E. (2001) MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin. Exp. Immunol. 126, 441-446.
43. Xia, Y., Wikberg, J.E., and Chhajlani, V. (1995) Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport 6, 2193-2196.
44. Tatro, J.B. (1996) Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation 3(5), 259-284.
45. Penhoat, A., Jaillard, C., and Saez, J.M. (1989) Corticotropin positively regulates its own receptors and cAMP response in cultured bovine adrenal cells. Proc. Natl. Acad. Sci. U. S. A. 86, 4978-4981.
46. Liakos, P., Chambaz, E.M., Feige, J.J., and Defaye, G. (1998) Expression of ACTH receptors (MC2-R and MC5-R) in the glomerulosa and the fasciculata-reticularis zones of bovine adrenal cortex. Endocr. Res. 24, 427-432.
47. Gantz, I., Konda, Y., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G., Watson, S.J., DelValle, J., and Yamada, T. (1993) Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268(11), 8246-8250.
48. Butler, A.A., Kesterson, R.A., Khong, K., Cullen, M.J., Pelleymounter, M.A., Dekoning, J., Baetscher, M., and Cone, R.D. (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518-3521.
49. Getting, S.J., Gibbs, L., Clark, A.J.L., Flower, R.J., and Perretti, M. (1999) POMC gene derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release and inhibit neutrophil migration in acute experimental inflammation. J. Immunol. 162, 7446-7453.
50. Getting, S.J., Allcock, G.H., Flower, R., and Perretti, M. (2001) Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J. Leukoc. Biol. 69, 98-104.
51. Getting, S.J., Christian, H.C., Lam, C.W., Gavins, F.N., Flower, R.J., Schioth, H.B., and Perretti, M. (2003) Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J. Immunol. 170, 3323-3330.
52. Lam, C.W., Getting, S.J., and Perretti, M. (2005) In vitro and in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation. J. Immunol. 174, 2297-2304.
53. Guarini, S., Schioth, H.B., Mioni, C., Cainazzo, M., Ferrazza, G., Giuliani, D., Wikberg, J.E., Bertolini, A., and Bazzani, C. (2002) MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias. Naunyn Schmiedebergs Arch. Pharmacol. 366, 177-182.
54. Getting, S.J., Di Filippo, C., Christian, H.C., Lam, C.W., Rossi, F., D'Amico, M., and Perretti, M. (2004) MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct. J. Leukoc. Biol. 76, 845-853.
55. Alvaro, J.D., Tatro, J.B., Quillan, J.M., Fogliano, M., Elsenhard, M., Lerner, M.R., Nestler, E.J., and Duman, R.S. (1996) Morphine down regulates melanocortin 4 receptor expression in brain regions that mediate opiate addiction. Mol. Pharmacol. 50, 583-591.
56. Mountjoy, K.G., Mrtrud, M.T., Low, M.J., Simerly, R.B., and Cone, R.D. (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8(10), 1298-1308.
57. Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S.J., DelValle, J., and Yamada, T. (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268(20), 15174-15179.
58. Martin, W.J. and MacIntyre, D.E. (2004) Melanocortin receptors and erectile function. Eur. Urol. 45, 706-713.
59. Starowicz, K. and Przewlocka, B. (2003) The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci. 73, 823-847.
60. Buggy, J.J. (1998) Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. Biochem. J. 331(Pt 1), 211-216.
61. Taylor, A. and Namba, K. (2001) In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol. Cell Biol. 79, 358-367.
62. Luger, T.A., Scholzen, T.E., Brzoska, T., and Bohm, M. (2003) New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. N. Y. Acad. Sci. 994, 133-140.
63. Gantz, I., Shimoto, Y., Konda, Y., Miwa, H., Dickinson, C.J., and Yamada, T. (1994) Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200(3), 1214-1220.
64. Schioth, H.B., Mutulis, F., Muceniece, R., Prusis, P., and Wikberg, J.E.S. (1998) Discovery of novel melanocortin 4 receptor selective MSH analogues. Br. J. Pharmacol. 124, 75-82.
65. Sawyer, T.K., Sanfilippo, P.J., Hruby, V.J., Engel, M.H., Heward, C.B., Burnett, J.B., and Hadley, M.E. (1980) 4-Norleucine, 7-D-phenylalanine-alpha- melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. U. S. A. 77, 5754-5758.
66. Al-Obeidi, F., Castrucci, A.M., Hadley, M.E., and Hruby, V.J. (1989) Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J. Med. Chem. 32, 2555-2561.
67. Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J., and Cone, R.D. (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168.
68. Grieco, P., Han, G., Weinberg, D., Van der Ploeg, L.H., and Hruby, V.J. (2002) Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6. Biochem. Biophys. Res. Commun. 292, 1075-1080.
69. Martignoni, E., Godi, L., Pacchetti, C., Berardesca, E., Vignoli, G.P., Albani, G., Mancini, F., and Nappi, G. (1997) Is seborrhea a sign of autonomic impairment in Parkinson's disease? J. Neural Trans. 104, 1295-1304.
70. Brzoka, T., Kalden, D.H., Fastrich, M., Möller, M., Schiöth, H.B., Wikberg, J.E.S., and Luger, T. (1999) Two new α-melanocyte stimulating (α-MSH) analogues (MS05 and MS09) are potent immunomodulators in vivo and in vitro. J. Invest. Dermatol. 113, 482.
71. Ignar, D.M., Andrews, J.L., Jansen, M., Eilert, M.M., Pink, H.M., Lin, P., Sherrill, R.G., Szewczyk, J.R., and Conway, J.G. (2003), Regulation of TNF-α secretion by a specific melanocortin-1 receptor peptide agonist. Peptides 24, 709-716.
72. Hruby, V.J., Lu, D., Sharma, S.D., Castrucci, A.L., Kesterson, R.A., Al-Obeidi, F.A., Hadlley, M.E., and Cone, R.D. (1995) Cyclic lactam a-melanotropin analogues of NDP-a-MSH with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38, 3454-3461.
73. Kask, A., Rago, L., Mutulis, F., Pahkla, R., Wikberg, J.E., and Schioth, H.B. (1998) Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats. Biochem. Biophys. Res. Commun. 245, 90-93.
74. Lu, D., Willard, D., Patel, I.R., Kadwell, S., Overton, L., Kost, T., Luther, M., Wenbiao, C., Woychik, R.P., Wilkison, W.O., and Cone, R.D. (1994) Agouti protein is an antagonist of the melanocyte stimulating-hormone receptor. Nature 371, 799-802.
75. Wilson, B.D., Ollmann, M.M., Kang, L., Stoffel, M., Bell, G.I., and Barsh, G.S. (1995) Structure and function of ASP, the human homolog of the mouse agouti gene. Hum. Mol. Gen. 4(2), 223-230.
76. Voisey, J. and van Daal, A. (2002) Agouti: from mouse to man, from skin to fat. Pigment Cell Res. 15(1), 10-18.
77. Ollmann, M.M., Wilson, B.D., Yang, Y.K., Kerns, J.A., Chen, Y., Gantz I., and Barsh, G.S. (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135-138.
78. Fong, T.M., Mao, C., MacNeil T., Kalyani R., Smith T., Weinberg D., Tota, M.R., and Van der Ploeg, L.H.T. (1997) ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem. Biophys. Res. Commun. 237, 629-631.
79. Getting, S.J., Lam, C.W., Leoni, G., Gavins, F.N., Grieco, P., and Perretti M. (2006) [D-TRP8]-gamma-melanocyte stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a non-functional MC1R (recessive yellow e/e mouse). Mol. Pharmacol. 70(6), 1850-1855,
80. Holder, J.R. and Haskell-Luevano, C. (2004) Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies. Med. Res. Rev. 24, 325-356.
81. Sebhat, I.K., Martin, W.J., Ye, Z., Barakat, K., Mosley, R.T., Johnston, D.B., Bakshi, R., Palucki, B., Weinberg, D.H., MacNeil, T., Kalyani, R.N., Tang, R., Stearns, R.A., Miller, R.R., Tamvakopoulos, C., Strack, A.M., McGowan, E., Cashen, D.E., Drisko, J.E., Hom, G.J., Howard, A.D., MacIntyre, D.E., van der Ploeg, L.H., Patchett, A.A., and Nargund, R.P. (2002) Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium-3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J. Med. Chem. 45, 4589-4593.
82. Pogozheva, I.D., Chai, B.X., Lomize, A.L., Fond, T.M., Weinberg, D.H., Nargund, R.P., Mulholland, M.W., Gantz, I., and Mosberg, H.I. (2005) Interactions of human melanocortin 4 receptor with non peptide and peptide agonists. Biochemistry 44(34), 11329-11341.
83. Van der Ploeg, L.H., Martin, W.J., Howard, A.D., Nargund, R.P., Austin, C.P., Guan, X., Drisko, J., Cashen, D., Sebhat, I., Patchett, A.A., Figueroa, D.J., DiLella, A.G., Connolly, B.M., Weinberg, D.H., Tan, C.P., Palyha, O.C., Pong, S.S., MacNeil, T., Rosenblum, C., Vongs, A., Tang, R., Yu, H., Sailer, A.W., Fong, T.M., Huang, C., Tota, M.R., Chang, R.S., Stearns, R., Tamvakopoulos, C., Christ, G., Drazen, D.L., Spar, B.D., Nelson, R.J., and MacIntyre, D.E. (2002) A role for the melanocortin 4 receptor in sexual function. Proc. Natl. Acad. Sci. U. S. A. 99, 11381-11386.
84. Allard, J., Reynolds, D.S., and Edmunds, N.J. (2008) Potentiation of reflex erectile responses in the anaesthetized rat by the selective melanocortin receptor 4 agonist MB243. BJU Int. 102(8), 1029-1033.
85. Pontillo, J., Tran, J.A., Markison, S., Joppa, M., Fleck, B.A., Marinkovic, D., Arellano, M., Tucci, F.C., Lanier, M., Nelson, J., Sauders, J., Hoare, S.R.J., Foster, A.C., and Chen, C. (2005) A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice. Bioorg. Med. Chem. Lett. 15(10), 2541-2546.
86. Tucci, F.C., White, N.S., Markison, S., Joppa, M., Tran, J.A., Fleck, B.A., Madan, A., Dyck, B.P., Parker, J., Pontillo, J., Arellano, M., Marinkovic, D., Jiang, W., Chen, C.W., Gogas, K.R., Goodfellow, V.S., Saunders, J., Foster, A.C., and Chen, C. (2005) Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines. Bioorg. Med. Chem. Lett. 15(19), 4389-4395.
87. Herpin, T.F., Yu, G., Carlson, K.E., Morton, G.C., Wu, X., Kang, L., Tuerdi, H., Khanna, A., Tokarski, J.S., Lawrence, R.M., and Macor, J.E. (2003) Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties. J. Med. Chem. 46, 1123-1126.
88. Smalley, K. and Eisen, T. (2000) The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells. FEBS Lett. 476, 198-202.
89. Mandrika, I., Muceniece, R., and Wikberg, J.E. (2001) Effects of melanocortin peptides on lipopolysaccharide/interferon-gamma-induced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. Biochem. Pharmacol. 61(5), 613-621.
90. Kapas, S., Purbrick, A., and Hinson, J.P. (1995) Role of tyrosine kinase and protein kinase C in the steroidogenic actions of angiotensin II, alpha-melanocyte-stimulating hormone and corticotropin in the rat adrenal cortex. Biochem. J. 305(Pt 2), 433-438.
91. Englaro, W., Rezzonico, R., Durand-Clement, M., Lallemand, D., Ortonne, J.P., and Ballotti, R. (1995) Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J. Biol. Chem. 270, 24315-24320.
92. Ghosh, S. and Karin, M. (2002) Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl), S81-96.
93. Kalden, D.H., Scholzen, T., Brzoska, T., and Luger, T.A. (1999) Mechanisms of the antiinflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expression. Ann. N. Y. Acad. Sci. 885, 254-261.
94. Ichiyama, T., Okada, K., Campbell, I.L., Furukawa, S., and Lipton, J.M. (2000) NF-kappaB activation is inhibited in human pulmonary epithelial cells transfected with alpha-melanocyte-stimulating hormone vector. Peptides 21, 1473-1477.
95. Konda, Y., Gantz, I., DelValle, J., Shimoto, Y., Miwa, H., and Yamada, T. (1994) Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem. 269, 13162-13166.
96. Lam, C.W., Perretti, M., and Getting, S.J. (2006) Melanocortin receptor signalling in RAW264.7 macrophage cell line. Peptides 27(2), 404-412.
97. Bar-Ilan, A., Savion, N., Naveh, N., and Ilan, A.B. (1992) Alpha melanocyte stimulating hormone (alpha-MSH) enhances eicosanoid production by bovine retinal pigment epithelium. Prostaglandins 43, 31-44.
98. Luger, T.A., Scholzen, T., and Grabbe, S. (1997) The role of alpha-melanocyte-stimulating hormone in cutaneous biology. J. Invest. Dermatol. Symp. Proc. 2, 87-93.
99. Bohm, M., Schulte, U., Kalden, H., and Luger, T.A. (1999) Alpha-melanocyte-stimulating hormone modulates activation of NF-kappa B and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Ann. N. Y. Acad. Sci. 885, 277-286.
100. de Wied, D. (1999) Behavioural pharmacology of neuropeptides related to melanocortins and the neurohypophyseal hormones. Eur. J. Pharmacol. 375, 1-11.
101. Vrinten, D.H., Kalkman, C.J., Adan, R.A., and Gispen, W.H. (2001) Neuropathic pain: a possible role for the melanocortin system? Eur. J. Pharmacol. 429, 61-69.
102. Starowicz, K. and Przewlocka, B. (2003) The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci. 73, 823-847.
103. Beckwith, B.E., Tinius, T.P., Hruby, V.J., al-Obeidi, F., Sawyer, T.K., and Affholter, J.A. (1989) The effects of structure-conformation modifications of melanotropin analogs on learning and memory: D-amino acid substituted linear and cyclic analogs. Peptides 10, 361-368.
104. Klusa, V., Svirskis, S., Opmane, B., Muceniece, R., Skujins, A., Mutulis, F., Wikberg, J.E., and Schioth, H.B. (1998) Evaluation of behavioural effects of neural melanocortin receptor antagonists injected ICV and in VTA in rats. Neuropeptides 32, 573-580.
105. Smolnik, R., Perras, B., Molle, M., Fehm, H.L., and Born, J. (2000) Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone. J. Clin. Psychopharmacol. 20, 445-454.
106. Schioth, H.B., Lagerstrom, M.C., Watanobe, H., Jonsson, L., Vergoni, A.V., Ringholm, A., Skarphedinsson, J.O., Skuladottir, G.V., Klovins, J., and Fredriksson, R. (2003) Functional role, structure, and evolution of the melanocortin-4 receptor. Ann. N. Y. Acad. Sci. 994, 74-83.
107. Adan, R.A., Hillebrand, J.J., De Rijke, C., Nijenhuis, W., Vink, T., Garner, K.M., and Kas, M.J. (2003) Melanocortin system and eating disorders. Ann. N. Y. Acad. Sci. 994, 267-274.
108. Ellacott, K.L. and Cone, R.D. (2004) The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog. Horm. Res. 59, 395-408.
109. Luger, T.A., Brzoska, T., Scholzen, T.E., Kalden, D.H., Sunderkotter, C., Armstrong, C., and Ansel, J. (2000) The role of alpha-MSH as a modulator of cutaneous inflammation. Ann. N. Y. Acad. Sci. 917, 232-238.
110. Rheins, L.A., Cotleur, A.L., Kleier, R.S., Hoppenjans, W.B., Saunder, D.N., and Nordlund, J.J. (1989) Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J. Invest. Dermatol. 93, 511-517.
111. Hiltz, M.E. and Lipton, J.M. (1990) Alpha-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides 11, 979-982.
112. Robertson, B., Dostal, K., and Daynes, R.A. (1988) Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J. Immunol. 140, 4300-4307.
113. Lipton, J.M., Ceriani, G., Macaluso, A., McCoy, D., Carnes, K., Biltz, J., and Catania, A. (1994) Antiinflammatory effects of the neuropeptide alpha-MSH in acute, chronic, and systemic inflammation. Ann. N. Y. Acad. Sci. 741, 137-148.
114. Leoni, G., Patel, H.B., Sampaio, A.L., Gavins, F.N., Murray, J.F., Grieco, P., Getting, S.J., and Perretti, M. (2008) Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion. FASEB J. 22(12), 4228-4238.
115. Gatti, S., Colombo, G., Buffa, R., Turcatti, F., Garofalo, L., Carboni, N., Ferla, L., Fassati, L.R., Lipton, J.M., and Catania, A. (2002) alpha-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation 74, 1678-1684.
116. Murphy, M.T., Richards, D.B., and Lipton, J.M. (1983) Antipyretic potency of centrally administered alpha-melanocyte stimulating hormone. Science 221, 192-193.
117. Shih, S.T., Khorram, O., Lipton, J.M., and McCann, S.M. (1986) Central administration of alpha-MSH antiserum augments fever in the rabbit. Am. J. Physiol. 250, R803-806.
118. Huang, Q.H., Entwistle, M.L., Alvaro, J.D., Duman, R.S., Hruby, V.J., and Tatro, J.B. (1997) Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced fever. J. Neurosci. 17, 3343-3351.
119. Getting, S.J., Riffo-Vasquez, Y., Pitchford, S., Kaneva, M., Grieco, P., Page, C.P., Perretti, M., and Spina, D. (2008) A role for MC3R in modulating lung inflammation. Pulm. Pharmacol. Ther. 21(6), 866-873.
120. Raap, U., Brzoska, T., Sohl, S., Path, G., Emmel, J., Herz, U., Braun, A., Luger, T., and Renz, H. (2003) Alpha-melanocyte-stimulating hormone inhibits allergic airway inflammation. J. Immunol. 171, 353-359.
121. Getting, S.J., Lam, C.W., Chen, A.S., Grieco, P., and Perretti, M. (2006) Melanocortin 3 receptors control crystal-induced inflammation. FASEB J. 20(13), 2234-2241.
122. Rajora, N., Boccoli, G., Catania, A., and Lipton, J.M. (1997) alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18, 381-385.
123. Oktar, B.K., Ercan, F., Yegen, B.C., and Alican, I. (2000) The effect of alpha-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 21, 1271-1277.
124. Yoon, S.W., Lee, C.H., Kim, J.Y., Kim, J.Y., Sung, M.H., and Poo, H. (2008) Lactobacillus casei secreting alpha-MSH induces the therapeutic effect on DSS-induced acute colitis in Balb/c Mice. J. Microbiol. Biotechnol. 18(12), 1975-1983.
125. Getting, S.J., Schioth, H.B., and Perretti, M. (2003) Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) {alpha}-melanocyte stimulating hormone peptides. J. Pharmacol. Exp. Ther. 306, 631-637.
126. Kannengiesser, K., Maaser, C., Heidemann, J., Luegering, A., Ross, M., Brzoska, T., Bohm, M., Luger, T.A., Domschke, W., and Kucharzik, T. (2008) Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm. Bowel Dis. 14(3), 324-331.
127. Colombo, G., Buffa, R., Bardella, M.T., Garofalo, L., Carlin, A., Lipton, J.M., and Catania, A. (2002) Anti-inflammatory effects of alpha-melanocyte- stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 10, 208-216.
128. Catania, A., Gerloni, V., Procaccia, S., Airaghi, L., Manfredi, M.G., Lomater, C., Grossi, L., and Lipton, J.M. (1994) The anticytokine neuropeptide alpha-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. Neuroimmunomodulation 1, 321-328.
129. Star, R.A., Rajora, N., Huang, J., Stock, R.C., Catania, A., and Lipton, J.M. (1995) Evidence of autocrine modulation of macrophage nitric oxide synthase by a-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. U. S. A. 92, 8016-8020.
130. Ceriani, G., Diaz, J., Murphree, S., Catania, A., and Lipton, J.M. (1994) The neuropeptide alpha-melanocyte stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1, 28-32.
131. Yoon, S.W., Chun, J.S., Sung, M.H., Kim, J.Y., and Poo, H. (2008) alpha-MSH inhibits TNF-alpha-induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor kappaB signaling in human chondrosarcoma HTB-94 cells. Osteoarthritis Cartilage 16(1), 115-124.
132. Zhong, Y. and Bellamkonda, R.V. (2005) Controlled release of anti-inflammatory agent α-MSH from neural implants. J. Control. Release 106(3), 309-318.
133. Takaishi, H., Kimura, T., Dalal, S., Okada, Y., and D'Armiento, J. (2008) Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr. Pharm. Biotechnol. 9(1), 47-54.
134. Evans, J.F., Niu, Q.T., Canas, J.A., Shen, C.L., Aloia, J.F., and Yeh, J.K. (2004) ACTH enhances chondrogenesis in multipotential progenitor cells and matrix production in chondrocytes. Bone 35(1), 96-107.
135. Evans, J.F., Shen, C.L., Pollack, S., Aloia, J.F., and Yeh, J.K. (2005) Adrenocorticotropin evokes transient elevations in intracellular free calcium ([Ca2+]i) and increases basal[Ca2+]i in resting chondrocytes through a phospholipase C-dependent mechanism. Endocrinology 146(7), 3123-3132.
136. Gutman, A.B. and Yu, T.F. (1950) Effects of adrenocorticotropic hormone (ACTH) in gout. Am. J. Med. 9(1), 24-30.
137. Ben-Chetrit, E. and Levy, M. (1998) Colchicine: 1998 update. Semin. Arthritis Rheum. 28, 48-59.
138. Ritter, J., Kerr, L.D., Valeriano-Marcet, J., and Spiera, H. (1994) ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems. J. Rheumatol. 21(4), 696-699.
139. Gecse, A., Ottlecz, A., Farago, M., Forster, T., and Telegdy, G. (1980) Effect of ACTH on prostaglandin induced vascular permeability. Acta Physiol. Acad. Sci. Hung. 55(4), 305-311.
140. Getting, S.J., Christian, H.C., Flower, R.J., and Perretti, M. (2002) Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum. 46, 2765-2775.
141. Bingham, C.O., 3rd (2008) Emerging therapeutics for rheumatoid arthritis. Bull. NYU Hosp. Jt. Dis. 66(3), 210-215.
142. Dixon, W.G., Hyrich, K.L., Watson, K.D., Lunt, M., Galloway, J., Ustianowski, A., Symmons, D.P. (2009) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann. Rheum. Dis. [Epub ahead of print]
143. Wallis, R.S. (2009) Infectious complications of tumour necrosis factor blockade. Curr. Opin. Infect. Dis. 22(4), 403-409.
144. Gavins, F.N., Leoni, G., and Getting, S.J. (2006) Annexin 1 and melanocortin peptide therapy for protection against ischaemic-reperfusion damage in the heart. TheScientificWorldJOURNAL 6, 1008-1023.
145. Norling, L.V., Perretti, M., and Cooper, D. (2009) Endogenous galectins and the control of the host inflammatory response. J. Endocrinol. 201(2), 169-184.